Ironwood Pharmaceuticals , Nasdaq: IRWD
Developing a new treatment for irritable bowel syndrome and constipation.
Industry: Health Care
First Day Return: +3.6%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 11/20/2009 |
| Offer Price | $11.25 |
| Price Range $14.00 - $16.00 | |
| Offer Shares (mm) | 16.7 |
| Deal Size ($mm) | $188 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/02/2010 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $188 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cambridge, MA, United States |
| Founded | 1998 |
| Employees at IPO | 165 |
| Website www.ironwoodpharma.com | |
Ironwood Pharmaceuticals (IRWD) Performance
